Study Raises Questions Around Strategy To Prevent Malaria In Pregnant Women

New York Times: Study Calls a Malaria Preventive for Pregnant Women Into Question
“…To protect [pregnant women and their unborn babies from malaria], health agencies use ‘intermittent preventive treatment,’ or IPT, under which all pregnant women in [areas where falciparum malaria is common] are given doses of anti-malarial drugs at regular intervals, whether or not they are tested for the disease. But malaria fighters sharply disagree over how to do it, and a study recently published by The New England Journal of Medicine adds fuel to the debate…” (McNeil, 3/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.